Uotila L, Suttie J W
Med Biol. 1982 Feb;60(1):16-24.
Vitamin K is required for the posttranslational modification of liver precursors of prothrombin, blood coagulation Factors VII, IX, and X and additional proteins of undetermined functions in plasma and other tissues. This modification involves the formation of gamma-carboxyglutamic acid, an acidic amino acid needed for the interaction of these proteins with calcium ions. The vitamin is a cofactor of a unique microsomal carboxylase which requires the reduced form of vitamin K, CO2, and molecular oxygen. The vitamin is apparently oxidized to its 2,3-epoxide during the carboxylation reaction. Liver microsomes also contain an enzyme which catalyzes the reduction of the epoxide to the vitamin, vitamin K epoxide reductase, and a number of vitamin K reductases. The epoxide reductase appears to be the site of the anticoagulant action of 4-hydroxycoumarins, commonly used as oral anticoagulants.
维生素K是凝血酶原、凝血因子VII、IX和X以及血浆和其他组织中功能尚未确定的其他蛋白质的肝脏前体进行翻译后修饰所必需的。这种修饰涉及γ-羧基谷氨酸的形成,γ-羧基谷氨酸是这些蛋白质与钙离子相互作用所需的一种酸性氨基酸。维生素K是一种独特的微粒体羧化酶的辅助因子,该羧化酶需要还原形式的维生素K、二氧化碳和分子氧。在羧化反应过程中,维生素K显然被氧化成其2,3-环氧化物。肝脏微粒体还含有一种催化环氧化物还原为维生素K的酶,即维生素K环氧化物还原酶,以及多种维生素K还原酶。环氧化物还原酶似乎是常用作口服抗凝剂的4-羟基香豆素抗凝作用的位点。